Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide in Advanced Parkinson's Disease
NCT04182399Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of zonisamide in Parkinson's disease (PD) (3 arms), sponsored by Ain Shams University. Primary endpoints: Off motor daily time at 3 months and Levodopa related Dyskinesia at 3 months. Started Apr 2020; status: completed.
02
Drugs
zonisamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04182399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182399.